By Women were underrepresented in COVID-19 treatment clinical trials, and some racial and ethnic groups were underrepresented in COVID-19 prevention trials, according to a new meta-analysis conducted by Fred Hutchinson Cancer Center in collaboration with researchers from Beijing and London.
Large-scale review of COVID-19 clinical trials highlights multiple disparities
Close Up Scientist using microscope in laboratory room while making medical testing and research
Comments